发明授权
US08524883B2 Monohydrate of (1-{9-[4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopurin-2-yl}pyrazol-4-yl)-N-methylcarboxamide
有权
（1- {9- [4S，2R，3R，5R）-3,4-二羟基-5-（羟甲基）氧杂环戊烷-2-基] -6-氨基嘌呤-2-基}吡唑-4-基） -N-甲基甲酰胺
![Monohydrate of (1-{9-[4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopurin-2-yl}pyrazol-4-yl)-N-methylcarboxamide](/docs/US/2013-09-03/US08524883B2/abs.jpg.600x600.jpg)
- 专利标题： Monohydrate of (1-{9-[4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopurin-2-yl}pyrazol-4-yl)-N-methylcarboxamide
- 专利标题（中）： （1- {9- [4S，2R，3R，5R）-3,4-二羟基-5-（羟甲基）氧杂环戊烷-2-基] -6-氨基嘌呤-2-基}吡唑-4-基） -N-甲基甲酰胺
-
申请号： US13333872申请日： 2011-12-21
-
公开(公告)号： US08524883B2公开(公告)日： 2013-09-03
- 发明人: Jeff Zablocki , Elfatih Elzein , Robert Seemayer , Travis Lemons
- 申请人： Jeff Zablocki , Elfatih Elzein , Robert Seemayer , Travis Lemons
- 申请人地址： US CA Foster City
- 专利权人： Gilead Sciences, Inc.
- 当前专利权人： Gilead Sciences, Inc.
- 当前专利权人地址： US CA Foster City
- 代理机构： Foley & Lardner LLP
- 主分类号： C07H19/00
- IPC分类号： C07H19/00 ; C07H19/167 ; C07H19/173
![Monohydrate of (1-{9-[4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopurin-2-yl}pyrazol-4-yl)-N-methylcarboxamide](/abs-image/US/2013/09/03/US08524883B2/abs.jpg.150x150.jpg)
摘要：
Disclosed is a synthesis suitable for large scale manufacture of an A2A-adenosine receptor agonist, namely, (1-{9-[(4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopurin-2-yl}pyrazol-4-yl)-N-methylcarboxamide. Also, disclosed are polymorphs of this compound and methods for isolating a specific polymorph. Also, disclosed are pharmaceutical compositions and methods for preparing pharmaceutical compositions.
公开/授权文献
信息查询
